MARIANN SIMPSON: Open Payments
NPI 1245213883 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 46 payments from 18 companies in 2025. Trend: 2023 $977 · 2024 $1,076 · 2025 $922
Food & beverage: $877Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $151 |
| Lilly USA, LLC | 4 | $103 |
| Janssen Pharmaceuticals, Inc | 4 | $101 |
| Dexcom, Inc. | 2 | $68 |
| PFIZER INC. | 3 | $63 |
| Inspire Medical Systems, Inc. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Astellas Pharma US Inc | 2 | $40 |
Products named: SPRAVATO, QULIPTA, Dexcom G6 Transmitter, MOUNJARO, INSPIRE, CAPLYTA, Veozah, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
